Deteksi molekuler high-risk human papillomavirus pada wanita berisiko tinggi di Kota Jayapura, Papua
DOI:
https://doi.org/10.25170/djm.v25i2.7725Keywords:
DNA HR-HPV, Kota Jayapura, populasi kunci, skrining HPVAbstract
Pendahuluan: Infeksi high-risk human papillomavirus (HR-HPV) merupakan penyebab utama kanker serviks. Data molekuler lokal pada populasi kunci di Indonesia bagian timur masih terbatas. Penelitian ini bertujuan mendeteksi DNA HR-HPV dan mendeskripsikan distribusi HPV 16, HPV 18, dan HR-HPV non-16/18 pada wanita pekerja seks (WPS) di Kota Jayapura.
Metode: Studi potong lintang ini melibatkan 30 WPS. Swab serviks diperiksa dengan real-time polymerase chain reaction (qPCR) menggunakan assay yang mendeteksi HPV 16 dan HPV 18 secara terpisah serta melaporkan 12 genotipe HR-HPV lain sebagai kelompok gabungan non-16/18. Karakteristik responden dianalisis secara deskriptif.
Hasil: DNA HR-HPV terdeteksi pada 10 dari 30 responden (33,3%). Seluruh hasil positif berada pada kelompok non-16/18, sedangkan HPV 16 dan HPV 18 tidak terdeteksi. Sebanyak 25 responden (83,3%) belum pernah menerima vaksin HPV dan 15 responden (50,0%) melaporkan tidak pernah menggunakan kondom.
Kesimpulan: HR-HPV terdeteksi pada sepertiga responden dan seluruh hasil positif termasuk kelompok non-16/18. Temuan ini mendukung penggunaan skrining DNA HPV yang mampu mendeteksi spektrum HR-HPV secara luas dan layanan pencegahan terintegrasi. Interpretasi temuan dibatasi oleh ukuran sampel purposif yang kecil serta keterbatasan uji dalam mengidentifikasi genotipe individual non-16/18.
Downloads
References
1. Pimple S, Mishra G. Cancer cervix: epidemiology and disease burden. Cytojournal. 2022;19:21.
2. World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention [Internet]. 2nd ed. Geneva: World Health Organization; 2021. Available from: https://www.who.int/publications/i/item/9789240030824
3. Kementerian Kesehatan Republik Indonesia. Rencana aksi nasional eliminasi kanker leher rahim di Indonesia tahun 2023–2030 [Internet]. Jakarta: Kementerian Kesehatan Republik Indonesia; 2023. Available from: https://www.kemkes.go.id/id/rencana-aksi-nasional-ran-eliminasi-kanker-leher-rahim-di-indonesia-tahun-2023-2030
4. Paczkowska I, Siedlecki JA, Świć A, Bidziński M, Nowakowski A, Sarnowska E. The human papillomavirus—long studied but still not fully understood. Nowotw J Oncol. 2025;75(5):305–13.
5. Farahmand M, Moghoofei M, Dorost A, Abbasi S, Monavari SH, Kiani SJ, et al. Prevalence and genotype distribution of genital human papillomavirus infection in female sex workers in the world: A systematic review and meta-analysis. BMC Public Health. 2020;20(1):1455.
6. Abubakar BG. Taking it to their doorstep: outreach well-woman clinics in brothels for cervical cancer screening of female sex workers in North-Western Nigeria. BMC Cancer. 2025;25(1):1660.
7. Sebsibe S, Molla G, Getachew B, Eshetu Y, Gedefie A, Erkihun Y, et al. Molecular epidemiology of high-risk human papillomavirus infection and its predictive factors among women living with HIV in Northeast Ethiopia: A facility-based cross-sectional study. BMC Infect Dis. 2025;25(1):1437.
8. Bando EF, Said MSM, Sansuwito TB, Suyanto J. Cultural barrier and cervical cancer stigma on screening program in community: A systematic literature review. Public Health Indones. 2025;11(2):129–40.
9. Manga SM, Ye Y, Nulah KL, Manjuh F, Fokom-Domgue J, Scarinci I, et al. Human papillomavirus types and cervical cancer screening among female sex workers in Cameroon. Cancers (Basel). 2024;16(2):243.
10. Ding H, Jin H, Tang Y. HPV genotype distribution and cervical lesions in Chongqing: A comprehensive analysis of 229,770 females (2015–2023). BMC Infect Dis. 2025;25(1):760.
11. Baba SK, Alblooshi SSE, Yaqoob R, Behl S, Al Saleem M, Rakha EA, et al. Human papilloma virus (HPV) mediated cancers: An insightful update. J Transl Med. 2025;23:483.
12. Kabir IM, de Azambuja Ribeiro RIM. HPV and cervical cancer: From molecular diagnostics to emerging treatment approaches (review). World Acad Sci J. 2025;7(4):58.
13. Lestari DPO, Wellere AI, Brill IK, Sari NLPEK, Jolly PE, Piyathilake CJ. The impact of an educational program on cervical cancer knowledge among HIV-positive women in Bali, Indonesia. Int J Womens Health. 2024;16:1677–85.
14. Agus Somia IK, Purwanta MLA, Winarti NW, Dwija IBNP, Pidari DMP, Sawitri AAS, et al. Prevalence and risk factors of high-risk HPV and cervical abnormalities in HIV-positive women in Bali, Indonesia. BMC Infect Dis. 2025;25(1):432.
15. Muwonga Tukisadila J, Mboumba Bouassa RS, Tonen-Wolyec S, Loemba H, Muwonga J, Belec L. Syndemic synergy of HPV, HIV, and HSV-2 for oncogenic HPV replication in female sex workers. Trop Med Infect Dis. 2025;10(6):157.
16. do Nascimento GR, da Silva Santos AC, Silva NNT, Carneiro CM, Maia AS, de Sousa Melo LC, et al. Impact of vaccination, sociodemographic and behavioral factors on the prevalence of high-risk HPV infection in young women: A cross-sectional study in Minas Gerais, Brazil. Discov Public Health. 2025;22(1):646.
17. Sayem ASM, Atuhaire B, Siddique AR, Mahmud R, Kokebie MA, Musuka G. HPV vaccination campaigns in Ethiopia and Bangladesh: Strategic implementation, challenges, identifying best practices and lessons for success in low- and middle-income countries. Vaccine X. 2025;25:100685.
18. Ruhode N, Madanhire C, Tumushime MK, Gudukeya S, Muhonde ND, Hatzold K, et al. Perceptions of integrating cervical cancer screening with HIV and sexual and reproductive health services: Results from serial multiple methods studies among health workers and women in Zimbabwe. Reprod Health. 2025;22(1):259.
19. Wirtz C, Mohamed Y, Engel D, Sidibe A, Holloway M, Bloem P, et al. Integrating HPV vaccination programs with enhanced cervical cancer screening and treatment: A systematic review. Vaccine. 2022;40 Suppl 1:A116–23.
20. Beroza AJ, Rine SAA, Bikomeye JC, Magezi RK, Simple O, Dickson-Gomez J, et al. A scoping review of human papillomavirus and cervical cancer knowledge, attitudes, practices, and prevention among female sex workers in Africa. J Glob Health Rep. 2024;8:124465.
21. Vimpere L, Sami J, Jeannot E. Cervical cancer screening programs for female sex workers: A scoping review. Front Public Health. 2023;11:1226779.
22. Mensah K, Kaboré C, Zeba S, Bouchon M, Duchesne V, Pourette D, et al. Implementation of HPV-based screening in Burkina Faso: Lessons learned from the PARACAO hybrid-effectiveness study. BMC Womens Health. 2021;21(1):251.
23. Mhango P, Kumitawa A, Malata MP, Tang JH, Chipeta E, Kandeya B, et al. Acceptability, feasibility and appropriateness of integrating HPV self-sampling for cervical cancer screening into voluntary family planning services in Malawi. BMC Public Health. 2025;25(1):2615.
24. Macleod CI, Reynolds JH. Human Papilloma Virus infection and cervical cancer among women who sell sex in Eastern and Southern Africa: A scoping review. Womens Health (Lond). 2021;17:17455065211058349.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Damianus Journal of Medicine

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.



